Benefits of Intravenous L-Carnitine Supplementation in Long-Term Haemodialysis Patients

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/511335

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Carnitine allows the body to utilise fats in our diet, permitting normal functioning of the body. The applicants have shown that patients who receive long-term haemodialysis treatment have abnormal levels of carnitine and have demonstrated a link between these abnormal levels and some dialysis-related conditions. This study will determine whether supplementation with L-carnitine is beneficial in the treatment of some clinical disorders experienced by haemodialysis patients.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $406,648.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical biochemistry - inorganic elements and compounds

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Anaemia | Dyslipidaemia | Haemodialysis | L-Carnitine | Muscle Fatigue | Renal | Renal Diseases | Therapeutics

Related Links